Haoyuan Pharmaceutical and Zhongfu Technology Sign Strategic Cooperation Agreement
On August 5, Haoyuan Pharmaceutical and Zhongfu Technology formally signed a strategic cooperation agreement. The two parties will strengthen coordination between their industrial resources and professional capabilities, and actively explore opportunities for cooperation in the fields of innovative drug research and development and industrialization services. The agreement is intended to integrate the respective advantages of both companies and drive the development of related businesses.
Why this event matters
The event has a measured impact on 1 industry. The strongest current signal is positive for Pharmaceutical R&D Services, with intensity 30/100 and 60% confidence over a medium term horizon.
Impact figures are analytical estimates that combine direction, intensity, confidence and event importance. They are not investment advice.